Exploring the Relationship Between ICOPE Framework and Frailty Among Community-dwelling Elderly Individuals
NCT ID: NCT06140212
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
135 participants
OBSERVATIONAL
2023-12-02
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Three Frailty Screening Tools
NCT04835090
Impact of Chronic Disease Control and Aging Psychology on Outcomes of Frailty-Sarcopenia Syndrome in Ambulatory Geriatric Patients
NCT02160093
The Effects of Intelligent Intervention Programs on Hospitalized Elderly People With Frailty.
NCT06875024
Psychometric Properties of the Elderly Health Questionnaire Among Community-dwelling Older People
NCT04166123
Frailty in Daily Practice: Screening, Consultation and Education Activities
NCT04139837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Decline ICOPE group
The elderly individuals who have at least one impairment in ICOPE screening domains.
Montreal Cognitive Assessment (MoCA)
MoCA would be used to assess participants cognitive functioning.
Chinese ICOPE screening tool (self-administration and interview versions)
The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.
Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.
Non-decline ICOPE group
The elderly individuals who do not have any impairment in ICOPE screening domains.
Montreal Cognitive Assessment (MoCA)
MoCA would be used to assess participants cognitive functioning.
Chinese ICOPE screening tool (self-administration and interview versions)
The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.
Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Montreal Cognitive Assessment (MoCA)
MoCA would be used to assess participants cognitive functioning.
Chinese ICOPE screening tool (self-administration and interview versions)
The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.
Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Community-dwelling elderly
* Walking independently (with/without assistive devices)
Exclusion Criteria
* Being unable to give informed consent (e.g., aphasia, deafness, and blindness)
* Being unable to finish all the physical and screening assessment assessments
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li-Ying Wang, PhD
Role: STUDY_CHAIR
National Taiwan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
Taipei, Zhongzheng, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202310067RINC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.